AtriCure Graham Number from 2010 to 2026
| ATRC Stock | USD 36.80 1.27 3.34% |
Graham Number | First Reported 2010-12-31 | Previous Quarter 14.76 | Current Value 13.12 | Quarterly Volatility 0.86759314 |
Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.7 M, Total Revenue of 561.9 M or Gross Profit of 419.6 M, as well as many indicators such as Price To Sales Ratio of 3.37, Dividend Yield of 0.0 or PTB Ratio of 3.71. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
AtriCure | Graham Number | Build AI portfolio with AtriCure Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out the analysis of AtriCure Correlation against competitors. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 0.158 | Return On Assets | Return On Equity |
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.